Bioheaven360 Genotec, a leading biotechnology startup based in Delhi, has introduced its cutting-edge AI-powered genomics diagnostics platform to the Indian market. This next-generation platform is designed to enable early disease detection and deliver personalised treatment plans, aiming to revolutionise preventive healthcare in the country.
Developed in Collaboration with AIIMS, New Delhi
Bioheaven360 Genotec developed the platform through rigorous research and clinical trials in partnership with the All India Institute of Medical Sciences (AIIMS), New Delhi. By integrating deep phenotyping, the platform captures a wide range of patient data—spanning genetic information, lifestyle habits, biomarkers, and environmental factors. This comprehensive data enables the system to generate highly accurate cumulative risk assessments, identifying potential disease predispositions decades before symptoms emerge.
Transforming Preventive Healthcare Through Personalisation
Founder and CEO Dr. Shailendra Vyas shared the company’s vision for the platform:
“Our platform aims to revolutionize preventive healthcare by providing personalized recommendations to mitigate risks and improve overall health outcomes. We leverage the latest in genetic testing and data analysis. This empowers individuals to take informed, proactive steps toward a healthier future.”
He emphasized that the system goes beyond traditional diagnostics. It combines real-time data analysis with advanced predictive modeling. This approach offers actionable health insights.
AI-Driven Insights and Real-Time Learning
As reported by pharmabiz, the platform utilizes advanced machine learning algorithms that improve continuously by learning from each new dataset. With its self-learning capabilities, the system enhances diagnostic accuracy over time. Key features include:
- Deep phenotyping to collect detailed patient profiles
- AI-powered diagnostic support
- Cumulative risk assessment tools
- Real-time data processing and refinement
Expanding Focus Beyond Osteoporosis
Initially developed to detect osteoporosis at an early stage, the platform is now evolving to address a broader spectrum of chronic and complex conditions. Its architecture allows for the rapid analysis of intricate medical datasets, including genomic sequences, imaging reports, and biomarker profiles. This enables it to deliver insights faster and more precisely than traditional diagnostic methods.
Shaping the Future of Personalised Medicine in India
With this launch, Bioheaven360 Genotec positions itself at the forefront of precision medicine in India. By combining genomic science, AI, and preventive care, the platform offers a comprehensive solution that empowers individuals and clinicians alike to make better-informed health decisions.